In an industry-first, the company Synchron and Mount Sinai Hospital in New York have enrolled their first human patient in a U.S. clinical trial called COMMAND to evaluate an endovascular ...

Neurotechnology company Paradromics will test its device in a trial aimed at safely restoring speech for people with severe motor impairments. Paradromics, a neurotechnology developer, announced today ...

Science Corporation, the full-stack neural engineering and brain-computer interface (BCI) company focused on restoring and ...

The study will evaluate the long-term use of Connexus BCI for its ability to safely restore speech and enable computer control for people with severe motor impairment. AUSTIN, Texas--(BUSINESS ...

China’s first clinical trial of a technology that allows signals from the brain to control an external device has shown early signs of success, making it only the second country after the US to reach ...

Cognixion has announced a clinical trial that integrates its non-invasive EEG-based brain–computer interface (BCI) technology with the Apple Vision Pro with no surgery required. The aim of the trial ...

A review published in Advanced Science highlights the evolution of research related to implantable brain-computer interfaces (iBCIs), which decode brain signals that are then translated into commands ...

Michigan Medicine opened the Brain-Computer Interface Clinic — one of the first of its kind in the nation — on Dec. 16, 2025 to provide neurological assessments for patients with speech and motor ...

While Elon Musk’s Neuralink likes to say it’s “pioneering” brain-computer interfaces (BCIs), China’s BCI industry is already quietly moving from research to scale. A new wave of startups is racing to ...

California-based Cognixion is launching a clinical trial to allow paralyzed patients with speech disorders the ability to communicate without an invasive brain implant. Cognixion is one of several ...